TIAA CREF Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $16.8M | Buy |
196,120
+166,250
| +557% | +$14.2M | 0.01% | 785 |
|
|
2018
Q4 | $1.68M | Sell |
29,870
-1,529
| -5% | -$85.8K | ﹤0.01% | 2051 |
|
|
2018
Q3 | $2.57M | Buy |
31,399
+956
| +3% | +$78.2K | ﹤0.01% | 1989 |
|
|
2018
Q2 | $1.07M | Buy |
30,443
+6,195
| +26% | +$217K | ﹤0.01% | 2467 |
|
|
2018
Q1 | $497K | Sell |
24,248
-2,000
| -8% | -$41K | ﹤0.01% | 2742 |
|
|
2017
Q4 | $743K | Sell |
26,248
-1,183
| -4% | -$33.5K | ﹤0.01% | 2605 |
|
|
2017
Q3 | $853K | Buy |
27,431
+4,390
| +19% | +$137K | ﹤0.01% | 2592 |
|
|
2017
Q2 | $729K | Buy |
23,041
+6,541
| +40% | +$207K | ﹤0.01% | 2695 |
|
|
2017
Q1 | $374K | Sell |
16,500
-414
| -2% | -$9.38K | ﹤0.01% | 2886 |
|
|
2016
Q4 | $369K | Sell |
16,914
-1,941
| -10% | -$42.3K | ﹤0.01% | 2929 |
|
|
2016
Q3 | $497 | Hold |
18,855
| – | – | ﹤0.01% | 2846 |
|
|
2016
Q2 | $372K | Buy |
+18,855
| New | +$372K | ﹤0.01% | 2979 |
|